← Open Payments lookup

MAGDALENA DEATON: Open Payments

NPI 1285281303 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$986 in 48 payments from 12 companies in 2025. Trend: 2023 $57 · 2024 $509 · 2025 $986

Food & beverage: $968Education: $17
CompanyPaymentsAmount
GlaxoSmithKline, LLC.23$428
Verona Pharma, Inc.5$97
Takeda Pharmaceuticals U.S.A., Inc.3$82
GENZYME CORPORATION3$73
Regeneron Healthcare Solutions, Inc.3$72
Viatris Specialty LLC3$57
Boehringer Ingelheim Pharmaceuticals, Inc.2$43
Actelion Pharmaceuticals US, Inc.2$43
Avadel CNS Pharmaceuticals, LLC1$29
AstraZeneca Pharmaceuticals LP1$27

Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, Ohtuvayre, ARALAST, YUPELRI, OFEV, OPSUMIT.

Industry payments across TX — which companies pay providers there.